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Abstract Deep brain stimulation (DBS) of the subtha-
lamic nucleus (STN) is used to relieve motor symptoms of
Parkinson’s disease. A tripartite system of STN subdivi-
sions serving motoric, associative, and limbic functions
was proposed, mainly based on tracing studies, which are
limited by low numbers of observations. The evidence is
compelling and raises the question as to what extent these
functional zones are anatomically segregated. The majority
of studies indicate that there is anatomical overlap between
STN functional zones. Using ultrahigh-resolution magnetic
resonance imaging techniques it is now possible to visu-
alize the STN with high spatial resolution, and it is feasible
that in the near future stereotactic guided placement of
electrical stimulators aided by high-resolution imaging will
allow for more specific stimulation of the STN. The neu-
roanatomical and functional makeup of these subdivisions
and their level of overlap would benefit from clarification
before serving as surgical targets. We discuss histological
and imaging studies, as well as clinical observations and
electrophysiological recordings in DBS patients. These
studies provide evidence for a topographical organization
within the STN, although it remains unclear to what extent
functionally and anatomically distinct subdivisions
overlap.
Keywords Basal ganglia  Parkinson’s disease  Deep
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Introduction
The subthalamic nucleus (STN) lies deep within the brain
on top of the cerebral peduncle and plays a central role in
both the direct and indirect pathway of the basal ganglia
(Temel et al. 2005) (Fig. 1). Even though the nucleus itself
is not degenerated in Parkinson’s disease, it plays an im-
portant role as a target for deep brain stimulation (DBS) in
its treatment. Targeting of the STN to modulate its function
using DBS provides relief of severe motor symptoms and
significantly improves quality of life in Parkinson’s pa-
tients (Limousin et al. 1995; Volkmann et al. 2001; Ro-
driguez-Oroz et al. 2004). The exact mechanism through
which DBS exerts its clinical effect is still under debate
(Temel et al. 2007). DBS in the STN is not without risk.
Despite differences in definitions between individual re-
search groups, the occurrence of cognitive/psychiatric side
is consistently reported (Benabid et al. 2009). Case studies
describe rare neuropsychiatric side effects including apa-
thy, compulsive behavior, hypersexuality, cognitive dys-
function as well as clinical depression including suicide
(Temel et al. 2005), and a recent, larger study reports
emotional lability in patients receiving DBS in the STN as
well as in the internal segment of the globus pallidus (GPi)
(Odekerken et al. 2013).
We would like to note that a direct association between
DBS surgery and an increased risk for suicide ideation and
behavior has not been shown (Weintraub et al. 2013).
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Interestingly, the side effects correspond to other functions
of the basal ganglia and the STN in addition to its’ role in
motor control (Temel et al. 2005).
The STN is considered the main relay station of the
indirect pathway of the basal ganglia. Its action together
with signals from the direct inhibitory GABA-ergic path-
way modulates the activity of GPi and the reticular part of
the substantia nigra (SNr) (DeLong and Wichmann 2007).
The STN in turn is under the control of the GPe, cerebral
cortex, compact part of the substantia nigra (SNpc), dorsal
raphe nucleus, pedunculopontine tegmental nucleus, and
the centromedian/parafascicular thalamic complex (Fig. 1,
Parent and Hazrati 1995a, b).
A number of studies have investigated the anatomo-
functional organization within the STN. The tripartite
subdivision hypothesis proposes the existence of subdivi-
sions within the STN, corresponding to limbic, associative
and motor functions. We have recently raised the question
whether the tripartite subdivision hypothesis of the STN
needs revision, which has already led to a response from
other research groups underlining the interest in the dis-
cussion within the research field (Alkemade and Forstmann
2014; Lambert et al. 2015). The aim of this review is to
critically re-evaluate available literature on the
neuroanatomical organization within the STN in an attempt
to determine to what extent anatomofunctional subdivi-
sions within the STN show overlap, and whether they
support the existence of (largely) separated subdivisions.
We will summarize findings from tracing studies, histo-
logical studies in human and non-human primates, and
from in vivo imaging studies in healthy participants and
pathophysiological observations.
We would like to note that rodent studies have been
invaluable in increasing understanding of the STN. Animal
models that faithfully recapitulate the pathological hall-
marks of Parkinson’s disease are crucial for the under-
standing of the pathogenic pathways in vivo (Lee et al.
2012). However, as is the case for most if not all rodent
models for neuropsychiatric and neurodegenerative disor-
ders, no genetic mouse model recapitulates all features of
human Parkinson’s disease (Lee et al. 2012). In addition,
the STN’s anatomy shows clear species differences. In rats,
the STN is considered an open nucleus which means that
its’ dendrites extend into brain areas outside the STN
(Afsharpour 1985). In primates, STN dendrites are almost
exclusively restricted to the nucleus itself, and the STN is
therefore considered to be closed (Rafols and Fox 1976).
We acknowledge important progress made in the field by
Fig. 1 Schematic illustration of positioning of the STN and the
connectivity of functional putative subdivisions within the basal
ganglia thalamocortical a motor, b associative, and c limbic circuits.
Adapted from (Temel et al. 2005). Based on tracing studies in
monkeys using both antero- and retrograde tracings, anatomofunc-
tional subdivisions of the STN have been proposed. Cortical areas
involved in the motor circuitry include the primary motor, premotor,
and somatosensory cortex (a). Cortical areas involved in the
associative circuitry include the dorsolateral prefrontal cortex, as
well as the lateral orbitofrontal cortex (b). The associative circuits
include the direct and indirect pathway. The direct pathway runs via
the internal segment of the Globus Pallidus (GPi) and reticular part of
the Substantia Nigra (SNr) to the ventroanterior (VA) and centrome-
dian (CM) nuclei of the thalamus, and the circuit is closed by the
thalamocortical pathway back to the dorsolateral prefrontal cortex
(DLPC) and the lateral orbitofrontal circuit back to the lateral
orbitofrontal cortex (LOFC). The indirect pathway encompasses a
projection from the external part of the globus pallidus (GPe) to the
STN and GPi/SNr. The limbic circuitry involves limbic and
paralimbic cortices as well as hippocampus and amygdala
(c) (Temel et al. 2005). Although subdivisions are anatomically
separated in this illustration, evidence from tracing studies point
towards significant overlap of these subdivisions (Haynes and Haber
2013)
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rodent studies, but in the present review we will focus on
data obtained in primates. We made this choice, since
although to a large extent human and rodent data are
comparable, there may be small anatomical differences
present between subdivisions in distinct species. These
small differences may have large consequences for the
efforts that are made to specifically target the dorsolateral
part of the STN in order to minimize side effects associated
with the unwanted stimulation of associate and limbic parts
of the STN.
Data have been obtained in humans and non-human
primates using a number of research approaches. Each
approach has its merits, as well as limitations, which is
important for the interpretation of the research findings
(Table 1). We have structured the evidence for a topo-
graphical organization within the STN according to the
applied research approach.
Topographical organization within the STN
Tracing studies
Based on tracing studies using a variety of different tracers
several groups have provided evidence for the existence of
0–4 anatomofunctional subdivisions within the STN
(Alexander and Crutcher 1990; Parent and Hazrati 1995a,
b; Joel and Weiner 1997; Keuken et al. 2012; Haynes and
Haber 2013). A number of studies argue for the existence
of three subdivisions with separate input and output path-
ways (Alexander and Crutcher 1990; Parent and Hazrati
1995a, b; Joel and Weiner 1997; Haber 2003; Hamani et al.
2004). Subthalamic neurons projecting to the putamen and
to GPe are present in the dorsolateral part of the STN.
Neurons projecting to the caudate nucleus and GPi and SNr
were largely confined to the ventromedial part of the STN,
although the projections to the striatum are not as well
documented as those to the GP. Finally, neurons projecting
to the ventral GP were confined to medial tip of the STN
(Nauta and Cole 1978; Smith et al. 1990). Based on the
anatomical connectivity, the dorsolateral part of the STN
was defined as the motor part, the ventromedial part of the
STN as the associative part, and the medial STN as the
limbic subdivision of the STN (Fig. 1, Alexander and
Crutcher 1990; Parent and Hazrati 1995a, b; Joel and
Weiner 1997).
Tracing studies are technically challenging and caution
should be used interpreting the data. Joel and Weiner (Joel
and Weiner 1997) already pointed out that the body of
evidence obtained from primates is interpreted in different
ways by different researchers. The interpretation of these
studies is complicated by inherent limitations of these ex-
perimental setups. Limitations include the comparison of
results across different primate species, as well as modest
numbers of observations. Intensity of the labeling may vary
between injections, and injection sites are often small. This
may sometimes lead to an underestimation of anatomical
connectivity. Recently, Haynes and Haber (2013) pub-
lished an extensive and well-executed tracing study in 43
macaques to map anatomical connections to different
functional areas within the STN. 21 out of 48 injections
were analyzed. This study confirmed the topographical
organization of limbic, associative, and motor connections
within the STN and provided additional anatomical detail
(Haynes and Haber 2013). The authors report topo-
graphical organization within the STN based on the ana-
tomical connections to different cortical regions. Overlap
resulted from convergence of dense terminal fields from
predominantly neighboring cortical regions, as well as
from a wide spread of diffuse fibers resulting in overlap
from more distant cortical areas. Haynes and Haber argue
that projection fields of the STN may have been larger than
reported due to the use of small injection sites.
The anatomical detail provided by Haynes and Haber is
of importance for understanding side effects of DBS
treatment in patients with Parkinson’s disease (Haynes and
Haber 2013). It has been postulated that a subset of the
deleterious side effects of DBS may be related to the lo-
cation of the electric stimulator within the STN. Uninten-
tional targeting of the limbic and associative parts of the
STN has been hypothesized to cause limbic-behavioral side
effects (Mallet et al. 2007).
Table 1 Strengths and weaknesses of research techniques
Research technique Strengths Weaknesses
Tracing High level of anatomical detail, information on connective
properties
Usually low numbers of observations, highly dependent
on injection site and volume
Cytoarchitectural
approaches
High level of anatomical detail, information on chemical
properties of cell populations
No information on connectivity, no functional data
Structural imaging In vivo information Low level of anatomical detail
Functional imaging In vivo on distinct functions Low level of anatomical detail
Clinical
observations
Information on (dys)function Low level of anatomical detail, usually low number of
observations, not always normal brain function
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Conclusions tracing studies
Tracing studies in non-human primates provide evidence
for topographical organization within the STN. In general,
studies point toward topographical organization without
clear borders in the STN (Haynes and Haber 2013; Alke-
made 2013) (Fig. 2). Tracing studies are valuable, but also
technically challenging. Caution should be used when in-
terpreting these data, since the results are strongly affected
by placement and volume of the tracer injection. In addi-
tion, conclusions are often drawn based on a limited
number of observations (Alkemade 2013). We cannot ex-
clude that a substantial overlap exists between the putative
anatomofunctional subdivisions within the STN.
Cytoarchitectural studies
It is feasible that different functions within the STN are
regulated by different neurotransmitter systems. Strikingly
little is known about the functional neuroanatomy of the
human and non-human primate STN and results are often
preliminary and sometimes even contradictory. A sig-
nificant number of informative studies have been published
on rodents. Since this review is focused on the human and
non-human primate, we have not included studies on
rodents.
Glutamate
The STN exerts a strong glutamatergic excitatory effect on
the main basal ganglia output structures (Parent and Haz-
rati 1995a). The majority of subthalamic neurons were
reported to show glutamate immunoreactivity in squirrel
monkeys (Smith and Parent 1988). Glutamate acts via
metabotropic glutamate receptors mGluR1a and 5 that are
expressed in rhesus monkey STN (Kuwajima et al. 2004).
Immunoreactivity of these two receptors shows significant
overlap in STN and is concentrated in the synaptic area in
close proximity of GABA-ergic synapses (Kuwajima et al.
2004). The data on glutamatergic output of the STN do not
provide evidence for anatomically distinct subdivisions or
zonations.
GABA
Although the main output of the STN is glutamatergic, a
minority of STN cells express glutamate decarboxylase
(GAD), which catalyzes the conversion of glutamate into
GABA (Levesque and Parent 2005). The expression of
GABA transporter (GAT) 1, which removes GABA from
the synaptic cleft thereby terminating its’ action (Hirunsatit
et al. 2009), was present in most STN neurons (Augood
et al. 1999). These data are in line with other reports that
the glutamatergic STN neurons receive a massive GABA-
ergic innervation (Smith and Parent 1988), which fits with
the expression of a number of GABA-A and -B receptor
subunits as determined by in situ hybridization in monkeys
(Kultas-Ilinsky et al. 1998; Charara et al. 2000). Like
glutamatergic signaling, markers for GABA-ergic signal-
ing do not provide evidence for anatomical subdivisions
within the STN.
Dopamine
Tyrosine hydroxylase catalyzes the rate-limiting step in the
synthesis of catecholamines and is therefore crucial for
dopamine production. Although large numbers of tyrosine
hydroxylase immunoreactive axons pass above and through
the STN, these are presumed to mainly be axons passaging
through in the direction of the neostriatum (Hedreen 1999).
Occasional branches, which are morphologically indicative
of axon terminals, innervated the STN (Hedreen 1999).
The dopamine 1 receptor (D1R) was not expressed in hu-
man STN, whereas D2R showed weak expression (Hurd
et al. 2001). Zonation was not investigated. A second study
corroborated the absence of D1R from the STN; however,
this study also reported a lack of D2R hybridization signal
from the STN (Augood et al. 2000).
Serotonin
Serotonin strongly innervates monkey STN and shows
clear topographical variation. The anterior half of the STN
is more densely innervated as compared to the posterior
half. Variation in expression was not present along any
other of the brain axes (Parent et al. 2011). The human
STN shows numerous serotonin transporter (SERT) im-
munoreactive varicosities, innervating STN neurons, which
have not been further identified (Parent et al. 2011). The
human STN contains a small number of thick and beaded
Fig. 2 Topographical organization of the STN. a Schematic repre-
sentation of anatomically distinct functional subdivisions/zones of the
STN. b Alternative topographical organization of the STN without
strict anatomically delineated subdivisions. Reproduced from (with
permission) (Alkemade 2013)
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SERT positive varicose fibers and a few thin and varicose
fibers distributed according to a mediolateral decreasing
gradient, whereas the isolated SERT positive axon vari-
cosities appear uniformly distributed throughout the nu-
cleus (Parent et al. 2011). Serotonin (5HT) itself cannot be
detected in human postmortem tissue samples for technical
reasons, but its’ distribution has been described in monkeys
(Mori et al. 1985). Regional differences in 5HT fiber im-
munoreactivity were observed. Highest density was ob-
served in the medial and ventral parts of the STN. In the
rostral STN scattered tract fibers were observed. In the
central and caudal parts, parallel fiber segments were ori-
ented towards the lateral margin of the STN.
Enkephalin
Expression of receptors for endogenous opioids in the
human STN was investigated using RNA blotting, which
revealed the presence of several transcripts showing high
expression in the STN (Raynor et al. 1995). mRNA ex-
pression of the prepro-Enkephalin B gene was observed in
the STN in monkeys. An increased expression was present
during levodopa treatment in a model for Parkinson’s
disease in monkeys. However, STN subdivisions were not
investigated (Aubert et al. 2007).
Calcium-binding proteins
Calcium-binding proteins are used to differentiate between
distinct populations of interneurons in the basal ganglia
(Parent et al. 1996). The distribution of calcium-binding
proteins in the human STN shows clear zonation. Calre-
tinin-immunoreactive neurons are particularly present in
the ventromedial part of the human STN (Parent et al.
1996; Augood et al. 1999), parvalbumin is present in the
dorsolateral part of the STN, whereas calbindin does not
appear to be expressed in human STN (Augood et al.
1999). Despite the difference in zonal expression of cal-
retinin and parvalbumin, there was a significant overlap in
their immunoreactivity (Augood et al. 1999). These data
support a topographical organization without clear anato-
mical boundaries within the STN.
Conclusions cytoarchitectural studies
Evidence from postmortem studies supports a topo-
graphical organization within the STN based on the dis-
tribution of several markers found within the nucleus.
These findings are summarized in Table 2. Markers
showing an inhomogeneous distribution over the STN,
however, do not provide evidence for clear topographically
delineated subdivisions within the STN. Translation of
cytoarchitectural studies into function would rely on
speculation, but the complexity of the cytoarchitectural
staining patterns may suggest the existence of a number of
overlapping neuronal populations within the STN. It is
possible that overlapping neuronal populations with dis-




MRI techniques and equipment have rapidly developed
over the years. 3 Tesla imaging techniques have been
successfully applied in basic studies on the STN, as well as
surgical targeting of the STN (e.g., Lambert et al. 2012;
Polanski et al. 2015). Using state-of-the-art ultrahigh-
resolution 7 Tesla imaging techniques it is now possible to
visualize the border between the STN and SN in vivo (Cho
et al. 2010; Turner 2012; Keuken et al. 2012) (Fig. 3). The
improved contrast is promising for the improvement of
anatomy guided DBS (Abosch et al. 2010). Abosch et al.
(2010) defined three criteria along which optimal MRI for
delineation of the STN could be developed. Ideally,
imaging for clinical application including stereotactic
guided DBS surgery needs to provide 3 qualities: the
highest possible signal to noise ratio, the highest possible
image resolution with adequate contrast, and the minimum
possible image distortion (Abosch et al. 2010). We have
attempted to use iron to identify local differences within
the STN (de Hollander et al. 2014). Although there were
clear gradients of iron concentrations within the nucleus,
no anatomical subdivisions of the STN could be distin-
guished. Our efforts represent a first step in performing
in vivo quantifications in the STN. Interestingly, a recent
study utilized probabilistic tractography to investigate STN
subdivisions using cluster analyses (Lambert et al. 2012).
These studies support a somatotopic organization within
the nucleus. The authors suggest that it may be the case that
unique limbic and motor STN zones exist, and that the
associative zone presents an overlapping, somatotopically
arranged transition between the two.
Functional imaging
Motor function
Despite the current interest, still very little is known about
the STN’s normal function in relation to movement.
Movement is closely correlated with STN and pallidal
activations (Toxopeus et al. 2012). The impact of STN
dysfunction on movement is illustrated by the striking
Brain Struct Funct (2015) 220:3075–3086 3079
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effects of STN lesions, which cause involuntary move-
ments in contralateral extremities (Crossman et al. 1984).
In addition, disruption of STN function causes impulsive
responses (Frank et al. 2007). A very recent study has in-
vestigated brain activation in healthy participants in rela-
tion to different aspects of movement. Ballistic movement
initiation, stepwise interrupted movement, step track, and
continuous circle movements were compared (Toxopeus
et al. 2012). Movement initiation was related to activations
in a number of areas including contralateral SN, caudate
head, bilateral putamen, and the posterior thalamus. STN
activation was related to movement inhibition, as was ac-
tivation in the ipsilateral pallidum, striatum, and dorsolat-
eral prefrontal cortex. Activations related to gradually
modulated movement and visuomotor control were located
in the bilateral pallidum, posterior dorsal putamen, bilateral
Table 2 Summary of histological observations
Protein/
mRNA
Function Human/monkey Zonation/subdivision References
mGlur1a G-protein-coupled receptors for glutamate M None reported Kuwajima et al. (2004)
mGlur5 G-protein-coupled receptors for glutamate M None reported Kuwajima et al. (2004)
GAD Glutamate decarboxylase, catalyzes the
conversion of glutamate to GABA
H None reported Levesque and Parent
(2005)
GAT1 GABA transporter 1 H None reported Augood et al. (1999)
GABA-A
receptor




G-protein-coupled receptors M None reported Charara et al. (2000)
TH Tyrosine hydroxylase, rate-limiting enzyme
in catecholamine production
H None reported Hedreen (1999)
DR2 Dopamine Receptor H None reported, expression in STN
is controversial
Hurd et al. (2001);
Augood et al. (2000)
SERT High affinity serotonin reuptake transporter H More staining in anterior STN as
compared to posterior
Parent et al. (2011)
5HT Serotonin M Highest density in medial and
ventral part of the STN
Mori et al. (1985)
ppEnkB prepro-Enkephalin B encodes Endogenous
opioid
M None reported Aubert et al. (2007)
Parvalbumin Calcium-binding protein H Clear zonation, higher
dorsolateral expression
Parent et al. (1996);
Augood et al. (1999)
Calretinin Calcium-binding protein H Clear zonation, higher
ventromedial expression
Parent et al. (1996);
Augood et al. (1999)
Fig. 3 Illustration of STN
visualization using T2*-
weighted 0.5 mm3 isotropic 7T
MRI. a Transverse view;
b coronal view; c sagittal view
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cerebellum, and primary motor cortex among other areas
(Toxopeus et al. 2012). These data suggest that STN in-
volvement in motor control is restricted to effects on motor
inhibition.
Associative function
The role of the STN in motor inhibition has been studied in
more detail. An increase in BOLD signal in the subtha-
lamic region has been observed in stop signal tasks (Aron
and Poldrack 2006; Li et al. 2008). A white matter network
including the STN, pre-supplementary motor area, and
inferior frontal cortex was uncovered in the right hemi-
sphere using diffusion-weighted MRI (DWI) tractography
(Aron et al. 2007; Boehler et al. 2010; Chikazoe 2010). In
addition, a hyperdirect pathway from cortex via STN has
been implicated (Aron and Poldrack 2006; Aron et al.
2007; Isoda and Hikosaka 2008). In this network, the STN
is considered to act as a relay station for action inhibition,
and these effects may be mediated via alterations in gamma
oscillations in the cortico-subthalamic connection (Aron
and Poldrack 2006; Frank 2006; Eagle et al. 2008; Alegre
et al. 2013).
Limbic function
Most reports on the limbic functions of the STN are related
to observations in pathology. Only few studies have in-
vestigated emotional processing. Bartels and Zeki (Bartels
and Zeki 2004) found activation in the STN area in relation
to maternal love. In addition, Karama et al. (Karama et al.
2011) showed that emotional movies induced STN acti-
vation. These studies unfortunately did not use high-
resolution scanning so that a detailed anatomical delin-
eation of the STN was not possible.
Conclusions in vivo imaging
In line with postmortem data, in vivo imaging studies
support zonation within the STN. Unfortunately, especially
older studies do not provide sufficient anatomical detail to
allow precise delineation of the STN. In these studies, often
an STN region containing the nucleus but also some sur-
rounding areas may have been included in the analyses.
Clinical observations
The role of the STN in motor function is evident from
STN lesions that produce violent, involuntary, flinging
movements known as ballism. Ballism is generally
confined to the side of the body contralateral to the lesion
(Parent and Hazrati 1995a, b). A case report described
hemiballism, persistent hypersexuality, as well as memory
and executive dysfunction in a patient after a subthalamic
infarction (Absher et al. 2000). Several studies have
aimed to investigate involvement of the STN in PD
pathology. A decreased STN BOLD signal was observed
in PD patients who had freezing of gait as compared to PD
patients who did not (Shine et al. 2013). Dysinhibition of
the STN by loss of dopaminergic input is thought to
contribute to the motor symptoms of Parkinson’s disease.
DBS improves these motor symptoms, but also affects
heart rate, mood, motivation, and sexual behavior (Kumar
et al. 1998; Limousin et al. 1998; Krack et al. 2000).
Common side effects include hypophonia, apathy,
euphoria/hypomania, stroke, and worsening of depressive
illness (Thobois et al. 2002; Wertheimer et al. 2014; Witt
et al. 2012) (Doshi et al. 2002). It should be noted that
side effects described in patients treated with DBS may in
some cases be related to the cessation of L-DOPA treat-
ment (Connolly and Lang 2014). Patients have also been
described to exhibit difficulties in their relations with
themselves, their spouses, their families, and their social
and professional environment (Schupbach et al. 2006).
Transient mania, pseudobulbar crying, and anxiety have
also been reported (Visser-Vandewalle et al. 2005; Chang
et al. 2012). However, in studies only including patients
without prior cognitive and psychiatric disorders, STN
stimulation improved mood, anxiety, and quality of life
without causing permanent psychiatric disorders or
modifying personality, or modifying social functioning
(Houeto et al. 2006). DBS of the STN induces abnormal
impulsivity in some PD patients, as illustrated by poor
inhibition in conflict-associated decision processes (Ja-
hanshahi et al. 2000; Frank et al. 2007), or when with-
holding movements (Ray et al. 2012).
Several studies have attempted to correlate the motoric
as well as the unwanted side effect of DBS to the anato-
mical location of the electrical stimulator. Clinical ob-
servations in two patients with hypomanic side effects
have shown that the hypomanic state was caused by
stimulation via the DBS contact located in the antero-
medial STN. The anteromedial contact, as well as a
contact more dorsal improved motor symptoms. Contacts
at the boundaries of the STN affected neither behavior,
nor motor performance (Mallet et al. 2007). The specific
properties of the DBS electrodes (placement, current
strength) are crucial to the exerted clinical effect, espe-
cially since DBS leads are relatively large (usually 4
contacts of 1.5 mm separated by 0.5 or 1.5 mm), and
currents inherently spread through the tissue to a certain
extent.
Brain Struct Funct (2015) 220:3075–3086 3081
123
Conclusions clinical observations
A number of medical conditions confirm the role of the
STN in movement, as well as associative, and limbic
processes. Some evidence for STN zonation or subdivi-
sions is present. These studies are complex due to the
number of different functions in which the STN is in-
volved. Additionally, studies are further complicated by
factors such as age, possible concomitant illness, and a lack
of control groups for comparison. Finally, it is important to
realize that confirmation of probe placement is not trivial.
Electrophysiological recordings in DBS patients
In addition to the therapeutic benefits of DBS surgery,
recordings during the implantation procedure have greatly
improved our understanding of the electrophysiological
properties of the human STN. It is important to note that
for obvious reasons such recordings can only be performed
in patients with a medical need for DBS. It therefore re-
mains unclear to which extent the observations can be
translated to normal STN function. Electrophysiological
recordings in PD patients support the presence of a motor
subdivision in the dorsolateral part of the STN (Rodriguez-
Oroz et al. 2001). This was assessed by measuring
modulation of the neuronal discharge in relation to passive
and active movements of the contralateral limbs (Ro-
driguez-Oroz et al. 2001; Abosch et al. 2002). Comparison
of electrophysiological properties of obsessive–compulsive
disorder (OCD) and PD STN’s revealed differences in
oscillation characteristics of STN neurons. STN firing rates
in OCD were lower than in PD. In line with this, OCD
patients showed longer interspike intervals. Interestingly,
the interspike interval was longer in the putative motor area
as compared to the limbic/associative subdivision of the
STN (Welter et al. 2011). These data suggest that different
parts of the STN are involved in the pathogenesis of OCD
and PD.
Coherence has been widely used to quantify similarity
between neuronal oscillations and is commonly interpreted
as interaction or communication between brain areas (Fries
2005; Schnitzler and Gross 2005). Topographical differ-
ences of tremor-associated coherence suggest that the
subthalamic area in patients with PD is further organized in
distinct segregated ‘tremor clusters’ that are specific for
rest and postural tremor activity (Reck et al. 2010). By
combining magnetoencephalography (MEG) and local field
potentials (LFP), frequency-dependent interactions be-
tween STN and cortex have been mapped. These studies
have revealed distinct couplings between STN and cortex
in PD patients: One with the motor cortex in the beta
frequency band and one with temporal areas in the alpha
frequency band (Hirschmann et al. 2011). Several studies
in PD patients have shown an increased beta-band activity
in this area, especially in the dorsal region of the STN
(Chen et al. 2006; Weinberger et al. 2009). Further studies
have revealed theta coherence in mesial and lateral sub-
thalamic area, alpha and lower beta coherence in the mesial
and ipsilateral motor areas, in addition to upper beta co-
herence the midline cortex. LFPs in the subthalamic areas
led electroencephalography (EEG) in the theta band. In
contrast, EEG led the depth LFP in the lower and upper
beta bands. LFP activity in the alpha band could either lead
or lag EEG. Thus, there are several functional sub-loops
between the subthalamic area and cerebral cortical motor
regions, distinguished by their frequency, cortical topog-
raphy, and temporal relationships (Fogelson et al. 2006).
These data support the presence of subdivisions or zonation
within the STN. Unfortunately, the resolution was too low
to firmly establish if recordings were made from the STN,
or as stated by the authors in the subthalamic area.
Further studies in PD patients revealed that pleasant,
unpleasant, and neutral stimuli evoked an event-related
potential (ERP). The magnitude of the effects was maximal
in the ventral part of the STN and dependent on dopamine
medication (Buot et al. 2012).
Conclusions electrophysiological recordings
in DBS patients
DBS stimulation has profound effects on STN function,
although stimulation of adjacent brain areas cannot be
excluded (Fontaine et al. 2004; Mallet et al. 2008).
Concluding remarks
The need for a better understanding of the STN’s func-
tional neuroanatomy is evident, both for increasing insight
in the pathogenesis of movement disorders as well as op-
timization of DBS for improvement of motor symptoms
and prevention of unwanted side effects. In all of the
studies describing anatomofunctional subdivisions or zones
within the STN we have reviewed, the respective authors
carefully discuss the existence of topographical overlap
between the subdivisions. The magnitude of the overlap is
of clinical relevance. With the development of new high-
resolution MRI techniques in combination with in vivo
electrophysiological measures during stereotactic surgery,
and technical advancements in the available electrical
stimulators, DBS will potentially become even more
valuable in the future. It is feasible that neurosurgeons will
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be able to selectively target the specific parts of the STN.
However, we feel that at present the evidence supporting
the existence of subdivisions of the STN without infor-
mation on the degree of overlap between these subdivisions
is insufficient to provide surgeons with specific targets
within the STN. We have reviewed support for STN sub-
divisions from different research disciplines within the
field of neuroscience. A topographical organization within
the STN may be present; however, it remains unclear to
what extent functional and anatomical subdivisions/zones
overlap. This review and recent publications by us and
others (Alkemade and Forstmann 2014; Lambert et al.
2015) indicate that the discussion on the tripartite subdi-
vision hypothesis of the STN is still ongoing. This dis-
cussion may inspire new anatomical studies as well as
studies developing computational models aimed to answer
questions on parallel vs. convergent/divergent signaling.
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